PALM BEACH, FL, March 05, 2018 -- Vegalab, Inc. ("Vegalab” or “the Company"), (OTCQB: VEGL), announced today that it completed its acquisition of The Agronomy Group, LLC effective as of February 1, 2018. The Agronomy Group (“TAG”), located in Tulare County, California, is a producer and distributor of environmentally friendly agrochemicals. TAG had been Vegalab’s top U.S. sales organization, so the acquisition dramatically expands the Company’s internal marketing capability. The purchase price for TAG was paid by the delivery of 600,000 shares of the restricted common stock of Vegalab, and a warrant to purchase 1,600,000 shares of the restricted common stock of Vegalab at an exercise price of $1.20 per share exercisable over a term of five years.
David Selakovic, CEO of Vegalab, Inc., said, “Vegalab’s acquisition of The Agronomy Group puts us in direct relationship with industry leading, national agro-chemical distributors and dealers such as Winfield United, Stanislaus Farm Supply, Buttonwillow Warehouse, and Mid Valley Agricultural Services. We are excited about the potential to increase our sales with the addition of 29 new products from TAG, including 10 of which are listed for use in organic agriculture (9 by the Organic Materials Review Institute, and 1 by the Washington State Department of Agriculture). Our management team determined this to be a highly strategic acquisition opportunity, and we expect TAG’s environmentally friendly products and established distribution channels to substantially increase our revenues and profitability.”
About Vegalab, Inc.
Vegalab, Inc. is the exclusive distributor in North and South America of a line of all-natural, biologically derived pesticides, fertilizers, and specialty agricultural products. Vegalab’s pesticides are highly effective against targeted organisms, non-toxic to beneficial organisms, and safe for the environment. Vegalab products support a healthy soil biome and are cost competitive with synthetic chemicals that do just the opposite.
Safe Harbor for Forward-looking Statements
This news release may contain forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company's progress, business opportunities, and growth prospects, they are based on management's current beliefs and assumptions as to future events. However, since the company's operations and business prospects are always subject to risk and uncertainties, the forward-looking events and circumstances discussed in this news release might not occur, and actual results could differ materially from those described, anticipated, or implied. For a more complete discussion of such risks and uncertainties, please refer to the company's filings with the Securities and Exchange Commission
Contact: Sean Leous Media Relations Vegalab, Inc. 636 US Highway 1, suite 110 North Palm Beach, FL 33408, US T + 800 208 1680 ext 714 http://vegalab.us


UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
OpenAI Restricts Astra AI Over Cyberattack Risks
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 



